Recently, a moderate increase in the prevalence of pertussis, possibly contracted from adults, has been observed among unvaccinated children. During a 3-year period, we prospectively enrolled 93 index patients with a polymerase chain reaction (PCR) and/or culture result positive for Bordetella pertussis. Among 63 household contacts of 28 index patients, PCR and culture for B. pertussis identified 25 B. pertussis-positive persons. Nineteen of 25 B. pertussis-positive household contacts were asymptomatic. Isolates were available from 10 families of both index patients and household contacts for molecular typing by pulsed-field gel electrophoresis (PFGE) and for genotyping of pertactin and pertussis toxin by sequence-specific PCR and sequencing. PFGE demonstrated homogeneity among the isolates recovered from within each family but heterogeneity among the isolates recovered from different families. B. pertussis isolates recovered from index patients and their household contacts were indistinguishable by molecular typing, demonstrating that identical strains can cause full pertussis disease in children and asymptomatic infection in adults and adolescents.
Widespread vaccination in Belgium and many other countries has resulted in a dramatic decrease in the incidence of pertussis and has protected several generations of children against potentially fatal disease. Several surveillance studies conducted in the 1990s have indicated that the incidence of pertussis may be increasing among adults and adolescents and possibly even among unvaccinated children [1] [2] [3] [4] [5] . These authors warn about underreporting and diagnostic dif-ficulties in vaccinated populations. In Belgium, we observed a moderate increase in the number of cases of Bordetella pertussis infection, from 0.04 cases per 100,000 inhabitants in 1996 to 0.81 cases per 100,000 inhabitants in 2000 [6] , without observing a large outbreak of infection, as was reported in other countries (e.g., The Netherlands and Canada) [7] .
Whether there has been a real increase in the incidence of pertussis or whether there was only underreporting in the past remains unclear. Nevertheless, the increase in the number of reported cases among nonimmunized children seems to be real in some countries [3, 8] and is possibly due to the high risk of acquiring infection from adults, who may play an important role as a reservoir of pertussis [2, 9] . However, until now, there has been no evidence that the morbidity associated with pertussis is not related to specific clones; rather, it has been related to the age and vaccination status of the patient and the time that has elapsed since the previous vaccination or infection.
PFGE is a powerful technique for molecular typing of B. pertussis [10] that has proven to be a valuable tool for identifying pertussis reservoirs and for studying transmission patterns [11] . DNA polymorphism analysis of pertactin and pertussis toxin has previously been used as typing method for the detection of vaccine-induced antigenic shifts [12] [13] [14] [15] . The aim of this prospective study was to detect B. pertussis infection by PCR and culture among household members of infants and children with whooping cough and to track person-to-person transmission of B. pertussis in families by differentiating the isolated B. pertussis strains with use of these molecular methods.
PATIENTS, MATERIALS, AND METHODS
From February 1999 through January 2002, we prospectively enrolled children in whom pertussis was clinically suspected and was confirmed by culture and/or PCR; we defined these patients as "index patients." Our microbiology department (Academisch Ziekenhuis-Vrije Universiteit Brussel, Brussels, Belgium) serves as a reference laboratory for B. pertussis, and a total of 1307 samples from our own hospital (obtained from inpatients) and from referring hospitals (referrals) were handled during this study period. As soon as pertussis was diagnosed on the basis of either PCR or culture results in the index patients, we obtained nasopharyngeal aspirate specimens from household contacts for performance of pertussis culture and PCR to identify the contamination source. Data on the age of, vaccination data for, and clinical symptoms of both index patients and household contacts were collected by questioning the parents. Because the aim of our study was to detect pertussis infection and to track person-to-person transmission of B. pertussis in families, we only included index patients for whom consent was obtained for examination of samples from household contacts.
For several years, culture and PCR of nasopharyngeal aspirate specimens for pertussis have been routinely performed at our microbiology department for the aforementioned indications. For this prospective study, the use of the aliquots for typing by PFGE, sequence-specific PCR, and sequencing analysis and the publication of the results were approved by the Ethics Committee of Academisch Ziekenhuis-Vrije Universiteit Brussel, and informed consent was obtained from all parents.
PCR and culture were mostly performed using nasopharyngeal aspirate specimens, although nasal or throat swab specimens and bronchoalveolar lavage fluid samples were occasionally used. Nasopharyngeal aspirate specimens were obtained by instilling 10 mL of 0.9% saline in one nostril, followed immediately by reaspiration of the fluid through a catheter (female bladder catheter CH08; Pharma-Plast) in the other nostril. The samples were cultivated on Regan-Lowe charcoal agar (Charcoal Agar; Oxoid) containing 10% horse blood and cephalexin (Bordetella Selective Supplement; Oxoid) and were incubated at 35ЊC for 7 days. At the same time, part of the sample was used for the detection of the B. pertussis-specific IS481 insertion element by PCR [16] . To monitor PCR inhibition, the pRRP100 plasmid was added as an internal positive control, as described elsewhere [16] .
For all positive cultures, the genetic diversity and the polymorphism in the pertactin and pertussis toxin virulence factors of the isolated B. pertussis strains were determined using methods adapted from Mooi et al. [7] . Chromosomal DNA was digested with XbaI and SpeI, and the obtained fragments were analyzed on the CHEFF DRII PFGE apparatus (BioRad) with 1% agarose in 0.5ϫ
, with use of modified electrophoresis conditions (initial switch time, 5 s; final switch, 35 s; voltage, 6 volts/cm; and run time, 24 h). Gels were subsequently stained with ethidium bromide, and the band patterns were analyzed using GelCompar software (Applied Maths).
Previous analysis of 177 Belgian isolates showed that 30 PFGE types could be differentiated by combining the 15 genotypes obtained with XbaI and the 13 genotypes obtained with SpeI [17] . The pertactin (prn) gene polymorphism was determined by 2 sequence-specific PCRs that used primers designed to hybridize in the polymorphic region of the prn gene and on the basis of the available sequence data (EMBL/GenBank database): the sense primers prnC (5 -GTGCGGTTCCCGGCG-GTG-3 ) and prnE (5 -TGCGGTTCCCGGCGGCTTC-3 ), recognizing the GGAVP and GGFGP repeats, respectively; and the antisense primer prnD (5 -GCTCCACGCTGGAGCCCG-3 ), recognizing a region downstream of the polymorphic region. The PCR was performed on a resuspended boiled colony with conditions described elsewhere [16] . On the basis of the obtained length of the amplified PCR products in the 2 PCR reactions, this method allowed us to differentiate the B. pertussis isolates into 6 groups of alleles: prn1/6/7, prn2, prn3, prn4/8, prn5, and prn9. Amplification and sequencing of the polymorphic domain of the pertussis toxin subunit 1 gene (ptxS1) was performed as described elsewhere [7] ; this allowed us to differentiate the 4 known alleles (ptxS1A, ptxS1B, ptxS1D, and ptxS1E).
RESULTS
We enrolled 93 index patients (41 girls and 52 boys). Twentysix were inpatients, and 67 were referrals. All index patients were treated with either intravenous erythromycin or oral clarithromycin. Parental consent for study inclusion was obtained for 28 index patients. Nasopharyngeal aspirate specimens were obtained from 63 household contacts belonging to the families of these 28 index patients. In 18 of 28 families, у1 household contact (25 of 63 household contacts) was found to be infected Clinical symptoms were present before or at the time of diagnosis of pertussis in the index patient for only 6 of 25 B. pertussis-positive household contacts (table 1). The 2 youngest household contacts (a 4-month-old twin brother of patient 2 and a 6-month-old niece of patient 17) had typical symptoms of pertussis and presented with a paroxysmal cough, vomiting, and oxygen desaturation. Both household contacts of patient 10 presented with a severe cough, and 2 other household contacts presented with mild symptoms, such as rhinitis and mild coughing, which are not typical for pertussis. Nineteen B. pertussis-positive household contacts had no recollection of experiencing symptoms in the preceding 2 months and remained free of symptoms during the index patient's symptomatic period and у2-month follow-up period.
Like the B. pertussis-positive household contacts, the majority (26 of 38) of the B. pertussis-negative household contacts had been fully vaccinated with certainty; 1 had been incompletely vaccinated, and 4 had not been vaccinated. For 7 B. pertussis-negative household contacts, vaccination data were unavailable. At the time of diagnosis for the relevant index patients, 3 of 38 B. pertussis-negative household contacts had a cough of 2-3 weeks' duration. The remaining 35 B. pertus- sis-negative household contacts were and remained symptom free during the index patient's follow-up period. On the basis of these data, the computed ratio of infected persons to symptomatic persons in families was 2.7:1. Nineteen index patients in the 28 families had positive culture results, but only in the families of 10 index patients was an additional isolate cultured from у1 household contact. In the isolates recovered from these 10 families, the pertussis toxin was always type ptxS1A, and the pertactin recovered from index patients was always identical to that recovered from household contacts: namely, type prn2 or type prn3 (table 2) . PFGE resulted in one specific profile for each family, and the profiles differed between families. Three families (families 1, 7, and 8) harbored a PFGE type (B1) considered to be common in the Belgian population [17] , whereas the other families harbored rather uncommon PFGE types.
DISCUSSION
In the late 1950s, a national pertussis vaccination program was introduced in Belgium. This program has never been interrupted, and the coverage has been close to 90% of the population. Large outbreaks of infection have not been experienced, but, since 1996, we have witnessed a progressive moderate increase in the number of isolates in the reference laboratory, together with a moderate increase in the incidence of pertussis among infants, as has occurred in other countries [18] .
To our knowledge, this prospective family study, which commenced in 1999, is one of the few studies in which transmission of virus within the family was confirmed by molecular typing of the isolated B. pertussis strains. B. pertussis isolates recovered from index patients and their household contacts were indistinguishable. The homogeneity of the isolates recovered from contacts and from the primary case in the family supports the observations of other authors [8, 9, [19] [20] [21] [22] [23] [24] : well-vaccinated adolescents and adults play an important role in the epidemiology of pertussis by acting as reservoirs of spread to incompletely vaccinated or unvaccinated children. The mechanism of transmission of B. pertussis by symptom-free adolescents and adults is not clear at the present time. Culture-positive, symptom-free persons can probably pass the organism through close contact, as occurs in a family. However, in our study, 9 of 25 symptom-free, B. pertussis-infected household contacts were culture negative and only PCR positive (table 1) at the time of diagnosis for the index patients. If one takes into account the mean incubation period of 2 weeks and the decreased duration of nasopharyngeal carriage of B. pertussis in vaccinated persons [22] , it is very likely that, in these household contacts, viable B. pertussis strains in the nasopharynx had already been eliminated before the onset of symptoms in the index patients.
Three of 38 B. pertussis-negative household contacts presented with a severe cough that lasted for 2-3 weeks at the time that index patients received diagnoses, suggesting prior infection with B. pertussis. Although the remaining 35 B. pertussis-negative household contacts remained free of symptoms during the index patients' у2-month follow-up period, we can not exclude the possibility that symptom-free infection occurred in these household contacts during the follow-up period, because we did not obtain any additional nasopharyngeal aspirate specimens from these household contacts for PCR or culture. An important difference in clinical manifestations was noted between the index patients and their household contacts. During the past decade, typical pertussis disease has been repeatedly reported in both adolescents and adults [5, 9, [25] [26] [27] . However, in our study, as in other family studies that have used serological testing and culture and that have started with index patients who have typical symptoms of pertussis, the infected household contacts were nearly all symptom free [21, 28] . This supports the assumption that pertussis infection in adolescents and adults is highly underdiagnosed and underreported because of the lack of symptoms. Our findings also support the idea that primary vaccination protects well against full disease but not against infection [24, 28, 29] and that morbidity associated with pertussis is not only related to age and immunization status, but it is also related to the time that has elapsed since the previous vaccination or infection [9] .
In this family study, little variation in the genotypes of the most important virulence factors (i.e., pertussis toxin and pertactin) was observed, as was expected on the basis of the results obtained for 177 Belgian isolates typed previously [17] . All isolates in this family study harbored prn2 or prn3, as was the case for 52% and 36% of the 177 previously studied isolates, respectively. All isolates harbored the ptxS1A allele, as did 98% of the previously typed isolates. Because of the low number of different genotypes in our population, typing of these virulence factors was insufficient to track person-to-person spread of infection. However, monitoring of these virulence factors is important to survey vaccine-induced antigenic shifts, because it has been suggested that vaccines containing a single type of prn and ptx are the cause of antigenic shifts in the B. pertussis isolates [12] [13] [14] [15] .
On the other hand, PFGE typing demonstrated a high genetic variability among B. pertussis strains in Belgium, with a predominance of 3 types [17] . One of these 3 common PFGE types (type B1) also predominated in our small family study. Despite the heterogeneity in the PFGE profiles of the isolates recovered in our study, there was homogeneity in the PFGE profiles of the isolates within each family, supporting the possibility of intrafamilial transmission. Furthermore, infection with identical strains was responsible for very heterogeneous symptomatology, which suggests that the morbidity associated with pertussis is not related to specific clones.
To protect unvaccinated infants from secondary spread of B. pertussis from previously vaccinated close contacts, several measures have been considered in different countries, such as a strict vaccination policy starting at the age of 2 months and booster vaccinations with acellular vaccines. While awaiting universal recommendations for adolescent and adult booster vaccination, we suggest that all infected close contacts be identified, because early administration of adequate treatment will prevent further spread and outbreaks of infection. Although others disagree [30] , our findings strongly suggest that chemoprophylaxis should also be recommended for completely immunized and symptom-free close contacts.
In conclusion, our study confirms that transmission of B. pertussis from symptom-free individuals occurs in families. The challenge to reduce the incidence of pertussis in children by prevention of reinfection in adolescents and adults is very timely. This goal may be achieved by strictly applied policies of vaccination of all children, together with the universal administration of acellullar boosters.
